Loading institutional data...
Loading institutional data...
Held by 232 of 2,417 reporting institutions (95th percentile) — extremely crowded.
Data as of Q3 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading insider activity...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Solve the discounted cash flow backwards, then stress-test the assumptions.
The same 3 years as the 3-yr average, with the stock compensation of those years charged as a cost. Shares issued to employees are real dilution, so this asks what the business generates for existing holders.
To be worth $95.50 today, the market must believe free cash flow compounds 14.3%/yr for a decade (off $818.5M on the SBC-adjusted basis).
On the basis ($1.73B) the requirement is 4.1%/yr. The difference is what charging stock compensation costs.
The market's 14.3% is more conservative than its 7-yr track record.
Default is 10.0% — this company's computed cost of capital (computed WACC), the same rate the Analysis tab discounts at.
2-stage DCF · 0.29B shares (market data) · net debt -$1.27B
mean 475.9% · volatility σ 1065% · implied rate exceeded in 4/6 yrs
Central path = implied 14.3%/yr growth; shaded band = ±1σ (1065%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Ranked against 35 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-09-30.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| GOOG | $3.42T | 25.7× | 22.9× | 8.5× | 15.1% | 59.7% | 32.8% | 31.8% | 28.5% | 0.1× | 1,956 |
| META | $1.57T | 26.2× | 15.7× | 7.8× | 22.2% | 82.0% | 30.1% | 27.8% | 21.9% | 0.2× | 1,887 |
| APP | $76.8B | 23.4× | 17.9× | 14.0× | 70.0% | 87.9% | 60.8% | 156% | 59.0% | 0.2× | 327 |
| NBIS | $41.9B | 467.1× | — | 79.1× | 479% | 68.6% | 15.6% | 1.8% | 0.9% | — | — |
| ZM | $27.9B | 15.4× | 21.2× | 5.7× | 4.4% | 77.0% | 39.0% | 19.4% | 19.4% | -1.0× | 232 |
| BIDU | $26.0B | — | 110.5× | 1.4× | 1.2% | 43.9% | 4.3% | 2.1% | 1.8% | 13.0× | — |
| FLUT | $14.3B | — | 15.9× | 0.9× | 16.6% | 45.2% | -2.5% | -4.5% | -1.9% | 6.7× | — |
| FDS | $11.6B | 22.6× | 14.5× | 4.7× | 6.7% | 50.6% | 21.5% | 26.6% | 15.8% | 1.3× | 212 |
| PINS | $11.0B | 31.7× | 29.0× | 2.6× | 15.8% | 80.1% | 9.9% | 8.8% | 8.8% | -2.8× | 171 |
| DOCN | $10.5B | 35.6× | 39.3× | 11.7× | 15.5% | 59.9% | 28.8% | -904% | 20.5% | 3.5× | 112 |
| MTCH | $9.7B | 17.4× | 13.4× | 2.8× | 0.2% | 72.8% | 17.6% | -242% | 16.5% | 3.1× | 146 |
| SNAP | $9.0B | — | — | 1.5× | 10.6% | 55.0% | -7.8% | -20.2% | -7.9% | — | 120 |
| BZ | $7.2B | 39.4× | 15.6× | 6.1× | 17.3% | 85.1% | 33.1% | 13.7% | 13.7% | -1.4× | 42 |
| NIQ | $5.8B | — | 12.4× | 1.4× | 5.7% | — | -8.4% | -35.7% | -7.7% | 4.3× | 35 |
| TTD | $5.8B | 13.7× | 7.3× | 2.0× | 18.5% | 78.6% | 15.3% | 17.8% | 17.8% | -0.9× | 154 |
| WIX | $3.2B | 87.6× | 111.0× | 1.6× | 13.2% | 68.1% | 2.5% | -13.8% | -13.8% | -11.9× | 24 |
| MGNI | $3.1B | 22.6× | 20.4× | 4.3× | 6.9% | 62.7% | 20.3% | 15.7% | 9.8% | 0.0× | 60 |
| PPLI | $2.7B | — | — | 1.1× | -8.7% | 66.2% | -4.3% | -2.2% | -1.7% | — | — |
| GRND | $2.2B | 29.4× | 18.6× | 5.0× | 27.6% | — | 21.5% | 202% | 21.4% | 2.3× | 25 |
| RUM | $2.1B | — | — | 21.1× | 5.4% | -6.7% | -81.3% | -29.8% | -29.8% | — | 54 |
| DV | $2.1B | 45.2× | 13.7× | 2.8× | 13.9% | 82.2% | 6.8% | 4.5% | 4.5% | -1.9× | 61 |
| WB | $1.5B | 3.6× | 2.6× | 0.9× | 0.1% | 76.0% | 25.6% | 11.5% | 7.5% | -0.4× | 13 |
| TRIP | $1.1B | 29.7× | — | 0.6× | 3.1% | 92.3% | 2.1% | 6.2% | 2.2% | — | 56 |
| HSTM | $1.0B | 55.3× | 15.6× | 3.4× | 4.3% | — | 6.0% | 5.2% | 5.2% | -0.6× | 38 |
| TBLA | $936M | 26.6× | 12.5× | 0.5× | 8.3% | 29.8% | 2.2% | 4.7% | 4.2% | -0.3× | — |
Peers = companies sharing ZM's sector (Services-Computer Programming, Data Processing, Etc.) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $1.62B buybacks = $1.62B returned on $1.92B FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 9 years — and what it earned on reinvestment.
A cash-return story — far more went to shareholders than back into the business (mature, low-reinvestment).
Reinvestment has been productive — operating income grew well per dollar put in. Current ROIC on all capital: 19%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 9 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
EOD close · as of 2026-10-30
How a revenue dollar becomes profit — FY2026
Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it.
Each value shows its share of revenue below it (common-size).
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.87B 100.0% | $4.67B 100.0% | $4.53B 100.0% | $4.39B 100.0% | $4.10B 100.0% | $2.65B 100.0% | $622.7M 100.0% | $330.5M 100.0% | $151.5M 100.0% |
| Cost of Revenue | $1.12B 23.0% | $1.13B 24.2% | $1.08B 23.8% | $1.10B 25.1% | $1.05B 25.7% | $822.0M 31.0% | $115.4M 18.5% | $61.0M 18.5% | $30.8M 20.3% |
| Gross Profit | $3.75B 77.0% | $3.54B 75.8% | $3.45B 76.2% | $3.29B 74.9% | $3.05B 74.3% | $1.83B 69.0% | $507.3M 81.5% | $269.5M 81.5% | $120.7M 79.7% |
| Research & Development | $844.9M 17.4% | $852.4M 18.3% | $803.2M 17.7% | $774.1M 17.6% | $363.0M 8.9% | $164.1M 6.2% | $67.1M 10.8% | $33.0M 10.0% | $15.7M 10.4% |
| Selling, General & Admin | $392.9M 8.1% | $442.7M 9.5% | $579.6M 12.8% | $576.4M 13.1% | $482.8M 11.8% | $320.5M 12.1% | $86.8M 13.9% | $44.5M 13.5% | $27.1M 17.9% |
| Total Operating Expenses | $2.63B 53.9% | $2.72B 58.4% | $2.92B 64.6% | $3.05B 69.4% | $1.98B 48.3% | $1.17B 44.1% | $494.6M 79.4% | $263.3M 79.7% | $125.5M 82.9% |
| Operating Income | $1.12B 23.1% | $813.3M 17.4% | $525.3M 11.6% | $245.4M 5.6% | $1.06B 25.9% | $659.8M 24.9% | $12.7M 2.0% | $6.2M 1.9% | -$4.8M -3.2% |
| Pretax Income | $2.42B 49.8% | $1.32B 28.2% | $832.3M 18.4% | $249.3M 5.7% | $1.10B 26.9% | $678.0M 25.6% | $26.4M 4.2% | $8.3M 2.5% | -$3.5M -2.3% |
| Income Tax Expense | $522.1M 10.7% | $305.3M 6.5% | $194.8M 4.3% | $145.6M 3.3% | -$274.0M -6.7% | $5.7M 0.2% | $1.1M 0.2% | $765K 0.2% | $304K 0.2% |
| Net Income | $1.90B 39.0% | $1.01B 21.7% | $637.5M 14.1% | $103.7M 2.4% | $1.38B 33.6% | $672.3M 25.4% | $25.3M 4.1% | $7.6M 2.3% | -$3.8M -2.5% |
| Per Share | |||||||||
| EPS (Basic) | $6.32 | $3.28 | $2.12 | $0.35 | $4.64 | $2.37 | $0.09 | $0.00 | -$0.11 |
| EPS (Diluted) | $6.18 | $3.21 | $2.07 | $0.34 | $4.50 | $2.25 | $0.09 | $0.00 | -$0.11 |
| Weighted Avg Shares (Basic) | 300.5M | 308.0M | 300.7M | 296.6M | 296.3M | 283.9M | 233.6M | 84.5M | 78.1M |
| Weighted Avg Shares (Diluted) | 307.3M | 315.1M | 308.5M | 304.2M | 305.8M | 298.1M | 254.3M | 116.0M | 78.1M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
How much the company owes, how it's trended, and how comfortably it's serviced.
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest expense isn't separately reported — often netted into “other income (expense), net.”
Cash vs short-term debt unavailable.
Short-term / long-term split not separately reported.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-10-30
Where each multiple sits in its own 7-yr range · 32th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 7-yr history.
Is the profit real, and how strong is the balance sheet?
FY2026 · every deduction from revenue to net income
DuPont — the three levers
ROE 19% against ROIC 19% — 0% of the return on equity comes from leverage and buybacks rather than from the operating business.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 8.8× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 18.5 | 18.5 | 31.0 | 25.7 | 25.1 | 23.8 | 24.2 | 23.0 |
| Gross Profit | 81.5 | 81.5 | 69.0 | 74.3 | 74.9 | 76.2 | 75.8 | 77.0 |
| R&D | 10.0 | 10.8 | 6.2 | 8.9 | 17.6 | 17.7 | 18.3 | 17.4 |
| SG&A | 13.5 | 13.9 | 12.1 | 11.8 | 13.1 | 12.8 | 9.5 | 8.1 |
| Operating Income | 1.9 | 2.0 | 24.9 | 25.9 | 5.6 | 11.6 | 17.4 | 23.1 |
| Income Tax | 0.2 | 0.2 | 0.2 | -6.7 | 3.3 | 4.3 | 6.5 | 10.7 |
| Net Income | 2.3 | 4.1 | 25.4 | 33.6 | 2.4 | 14.1 | 21.7 | 39.0 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on ZM: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
Earns -0.28pts against its cost of capital — capital is being consumed, not created.
| Period | ROIC | Cost of capital | Spread |
|---|---|---|---|
| FY2020 | 1.5% | 10.0% (today's — no rate published for this year) | -8.5pts |
| FY2021 | 28.6% | 10.0% (today's — no rate published for this year) | 18.6pts |
| FY2022 | 16.8% | 10.0% (today's — no rate published for this year) | 6.7pts |
| FY2023 | 3.6% | 10.0% (today's — no rate published for this year) | -6.4pts |
| FY2024 | 6.1% | 10.0% (today's — no rate published for this year) | -3.9pts |
| FY2025 | 8.1% | 10.0% (today's — no rate published for this year) | -1.9pts |
| FY2026 | 10.0% | 10.0% (today's — no rate published for this year) | -0.0pts |
| Now | 19.4% | 10.0% | 9.4pts |
| Fiscal year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY2018 | 79.7% | -3.2% | -2.5% |
| FY2019 | 81.5% | 1.9% | 2.3% |
| FY2020 | 81.5% | 2.0% | 4.1% |
| FY2021 | 69.0% | 24.9% | 25.4% |
| FY2022 | 74.3% | 25.9% | 33.6% |
| FY2023 | 74.9% | 5.6% | 2.4% |
| FY2024 | 76.2% | 11.6% | 14.1% |
| FY2025 | 75.8% | 17.4% | 21.7% |
| FY2026 | 77.0% | 23.1% | 39.0% |
Return on equity (19%) and return on invested capital (19%) are within a couple of points in FY2026, so the headline return is the operating return — there is no meaningful leverage effect to strip out.
$599M of goodwill — 7% of invested capital. The gap is what was paid above the fair value of what was bought; it is real capital shareholders provided, so neither bar is the whole answer.
The spread is -0.28pts and would invert under a ±2% move in WACC, so the verdict rests on the cost-of-capital assumption rather than on the business.
Cash conversion is 3.52x but SBC is 15.63% of revenue.
Cash conversion is strong at 3.52x, but SBC is 15.63% of revenue — the cash flow looks clean partly because paying people in stock never passes through it.
Debt is present but there is no positive EBITDA or no reported interest expense, so coverage cannot be measured.
Balance sheet at 2026-01-31. Undrawn revolving credit is not shown: the tag is collected but not yet mapped through to the API.
No material counter-signal in the checked set: net debt / EBITDA, interest coverage, stressed coverage, maturity schedule vs cash and one year of FCF, liquidity ratios.
Missing from our data, so excluded from this answer: interest_expense.
At $95.50, free cash flow must compound 14.38%/yr for 10 years. It has done 74.86%/yr over 6 years after stock compensation.
| Fiscal year | FCF growth | Price requires |
|---|---|---|
| FY2021 | 2640.6% | 14.4% |
| FY2022 | −10.8% | 14.4% |
| FY2023 | −110.0% | 14.4% |
| FY2025 | 111.6% | 14.4% |
| FY2026 | 32.6% | 14.4% |
The percentile ranks the FISCAL-YEAR point, because the distribution behind each strip is built from fiscal-year closes — ranking a TTM figure inside it would compare two different bases. TTM basis: TTM (share count from the last fiscal year — the TTM window reports none).
This is solved on free cash flow AFTER stock compensation ($818M against $1.73B before it). On the unadjusted figure the requirement would be 4.15%/yr. Which is right depends on whether you think the share issuance is a recurring cost of running the business.
| Step | Amount | Running total |
|---|---|---|
| Net income | $1.90B | $1.90B |
| Share-based comp | $761M | $2.66B |
| Other non-cash & working capital | −$672M | $1.99B |
| Operating cash flow | $1.99B | $1.99B |
| Capex | −$65M | $1.92B |
| Free cash flow | $1.92B | $1.92B |
| FCF after SBC | $1.16B | $1.16B |
| Fiscal year | Revenue growth | Receivables growth | Gap |
|---|---|---|---|
| FY2021 | 325.8% | 144.7% | -181.1 points |
| FY2022 | 54.6% | 42.4% | -12.2 points |
| FY2023 | 7.2% | 32.8% | 25.7 points |
| FY2024 | 3.1% | -3.8% | -6.9 points |
| FY2025 | 3.0% | -7.6% | -10.7 points |
| FY2026 | 4.4% | 0.4% | -3.9 points |
| Fiscal year | DSO | DIO | DPO | Cash conversion cycle |
|---|---|---|---|---|
| FY2020 | 70.6 days | not reported | 5 days | 65.6 days |
| FY2021 | 40.6 days | not reported | 3.8 days | 36.7 days |
| FY2022 | 37.4 days | not reported | 2.7 days | 34.6 days |
| FY2023 | 46.3 days | not reported | 4.8 days | 41.5 days |
| FY2024 | 43.2 days | not reported | 3.4 days | 39.8 days |
| FY2025 | 38.7 days | not reported | 2.7 days | 36 days |
| FY2026 | 37.3 days | not reported | 2 days | 35.2 days |
| Fiscal year | Accruals / assets |
|---|---|
| FY2020 | -9.8 percent |
| FY2021 | -15.1 percent |
| FY2022 | -3.0 percent |
| FY2023 | -14.6 percent |
| FY2024 | -9.7 percent |
| FY2025 | -8.5 percent |
| FY2026 | -0.7 percent |
Below the line, the asset base is being consumed faster than it is replaced.
Below the line for 1 year to the latest.
Depreciation here includes amortisation of acquired intangibles — goodwill written down over time, customer lists, acquired technology. Capex does not replace those and is not meant to, so an acquisitive or asset-light company sits below 1.0 permanently and correctly. The signal is cleanest for capital-intensive businesses, where the two measure the same physical base. For that reason this informs the earnings-quality verdict but never caps it.
SBC is added back inside operating cash flow, so reported free cash flow treats shares issued to employees as free. Percent of revenue says how expensive the payroll is; percent of operating cash flow says how much of the cash exists only because the charge was added back. The buyback offset is buybacks over SBC — below 1.0 the repurchase does not cover the shares issued.
Figures are the latest fiscal year (FY2026) from the company's own filings, not a trailing-twelve-month window — Q2 reads fiscal years throughout so the cash-conversion ratios and these share one basis. A blank is a line the filer did not report; it is never read as zero.
Last reported position per insider, carried forward. Steps can be a holding disclosed for the first time rather than a trade.
| Date | Insider | What it was | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-28 | Subotovsky Santiago Director | 10b5-1 plan sale | 1,442 | $100.14 | $144k |
| 2026-10-22 | 9 co-filers Group filing | 10b5-1 plan sale | 20 | $100.43 | $2k |
| 2026-10-21 | Chang Michelle Chief Financial Officer | 10b5-1 plan sale | 10,156 | $101.93 | $1.0m |
| 2026-10-21 | Mcmaster Herbert Raymond Director | 10b5-1 plan sale |
Every row is classified by what it MEANT, not by its SEC code. A code is not a meaning: code P (“purchase”) also covers dividend reinvestment and employee stock purchase plans, and code S (“sale”) also covers 10b5-1 plan sales scheduled months earlier and option exercises sold the same day.
Across 30 days of all filings, $5.08bn of insider selling contained $3.50bn of plan sales and $0.46bn of exercise-and-sell. Only 29% was discretionary. Reading an unclassified feed badly overstates how much insiders decided.
Buys and sales are counted separately and never netted. They are different decisions by different people; a company where one officer bought while another sold is not “neutral”.
The holding line carries each insider's last reported position forward, so it shows the total held rather than a sawtooth of whoever traded that day. It covers only insiders who filed in the window.
“Filed late” counts calendar days past the two-business-day deadline with five days' grace, so a Thursday or Friday trade crossing a weekend is never flagged. It describes the company's filing discipline, not the trade.
Insider activity is descriptive. Nothing here is investment advice.
| 1,500 |
| $101.25 |
| $152k |
| 2026-10-21 | 9 co-filers Group filing | 10b5-1 plan sale | 3,436 | $100.49 | $345k |
| 2026-10-21 | 9 co-filers Group filing | 10b5-1 plan sale | 376 | $101.19 | $38k |
| 2026-10-15 | 9 co-filers Group filing | 10b5-1 plan saleindirect3d late | 35 | $93.65 | $3k |
| 2026-10-15 | 9 co-filers Group filing | 10b5-1 plan saleindirect3d late | 64 | $94.60 | $6k |
| 2026-10-15 | 9 co-filers Group filing | 10b5-1 plan saleindirect3d late | 84 | $95.44 | $8k |
| 2026-10-15 | 9 co-filers Group filing | 10b5-1 plan saleindirect3d late | 280 | $96.61 | $27k |
| 2026-10-15 | 9 co-filers Group filing | 10b5-1 plan saleindirect3d late | 88 | $97.40 | $9k |
| 2026-10-15 | 9 co-filers Group filing | 10b5-1 plan saleindirect3d late | 166 | $98.26 | $16k |
| 2026-10-13 | 4 co-filers Chief Accounting Officer | Tax withholding | 8,692 | $97.56 | $848k |
| 2026-10-12 | 5 co-filers Chief Financial Officer | 10b5-1 plan sale | 2,742 | $98.67 | $271k |
| 2026-10-12 | 5 co-filers Pres. of Engineering & Product | 10b5-1 plan sale | 2,346 | $98.63 | $231k |
| 2026-10-12 | 5 co-filers Pres. of Engineering & Product | 10b5-1 plan sale | 5,299 | $99.54 | $527k |
| 2026-10-12 | 5 co-filers Chief Financial Officer | 10b5-1 plan sale | 5,747 | $99.84 | $574k |
| 2026-10-09 | 3 co-filers Chief Executive Officer | Option exerciseindirect | 46,823 | $94.67 | $4.4m |
| 2026-10-09 | 4 co-filers Chief Accounting Officer | Option exercise | 3,121 | $0.00 | $0 |
| 2026-10-09 | 5 co-filers Chief Financial Officer | Option exercise | 22,218 | $0.00 | $0 |
| 2026-10-09 | 5 co-filers Pres. of Engineering & Product | Option exercise | 20,752 | $0.00 | $0 |
| 2026-10-09 | 5 co-filers Chief Financial Officer | Tax withholding | 8,743 | $94.67 | $828k |
| 2026-10-09 | 5 co-filers Pres. of Engineering & Product | Tax withholding | 10,559 | $94.67 | $1000k |
| 2026-10-09 | 4 co-filers Chief Accounting Officer | Tax withholding | 1,383 | $94.67 | $131k |
| 2026-10-09 | 3 co-filers Chief Executive Officer | Tax withholdingindirect | 23,824 | $85.68 | $2.0m |
| 2026-10-09 | 3 co-filers Chief Executive Officer | Option exercise | 46,823 | $0.00 | — |
| 2026-10-09 | 4 co-filers Chief Accounting Officer | Option exercise | 3,121 | $0.00 | — |
| 2026-10-09 | 5 co-filers Pres. of Engineering & Product | Option exercise | 20,752 | $0.00 | — |
| 2026-10-09 | 5 co-filers Chief Financial Officer | Option exercise | 22,218 | $0.00 | — |
| 2026-10-08 | Mcmaster Herbert Raymond Director | 10b5-1 plan sale | 3,000 | $94.71 | $284k |
| 2026-10-06 | 8 co-filers Chief Executive Officer | Otherindirect | 12,100 | $0.00 | $0 |
| 2026-10-06 | 8 co-filers Chief Executive Officer | 10b5-1 plan saleindirect | 11,896 | $94.07 | $1.1m |
| 2026-10-06 | 8 co-filers Chief Executive Officer | 10b5-1 plan saleindirect | 204 | $94.59 | $19k |
| 2026-10-06 | 8 co-filers Chief Executive Officer | Otherindirect | 12,100 | $0.00 | — |
| 2026-10-05 | 8 co-filers Chief Executive Officer | Otherindirect | 12,100 | $0.00 | $0 |
| 2026-10-05 | 2 co-filers Group filing | 10b5-1 plan sale | 2,525 | $93.72 | $237k |
| 2026-10-05 | 8 co-filers Chief Executive Officer | 10b5-1 plan saleindirect | 11,512 | $93.72 | $1.1m |
| 2026-10-05 | 2 co-filers Group filing | 10b5-1 plan sale | 112 | $94.24 | $11k |
| 2026-10-05 | 8 co-filers Chief Executive Officer | 10b5-1 plan saleindirect | 588 | $94.20 | $55k |
| 2026-10-05 | 8 co-filers Chief Executive Officer | Otherindirect | 12,100 | $0.00 | — |